tradingkey.logo

LifeMD Inc

LFMD
3.220USD
-0.010-0.31%
交易中 美東報價延遲15分鐘
150.00M總市值
虧損本益比TTM

LifeMD Inc

3.220
-0.010-0.31%

關於 LifeMD Inc 公司

LifeMD, Inc. is a provider of virtual healthcare services and pharmacy services. The Company offers telemedicine, access to laboratory and pharmacy services, and specialized treatment across 200 conditions, including primary care, men’s and women’s health, mental health, and weight management. Its Telehealth platform is end-to-end virtual healthcare directly to consumers and through select enterprise partnerships. In addition, the Company is focused on developing its Rex MD product portfolio, which is primarily focused on asynchronous men’s healthcare, e-pharmacy solutions, and men’s hormonal health. The Company owns a vertically integrated, proprietary digital care platform, a 50-state affiliated medical group, a state-of-the-art affiliated compounding pharmacy, and a United States based patient care center.

LifeMD Inc簡介

公司代碼LFMD
公司名稱LifeMD Inc
上市日期Jul 11, 2001
CEOSchreiber (Justin)
員工數量304
證券類型Ordinary Share
年結日Jul 11
公司地址236 Fifth Avenue
城市NEW YORK
上市交易所NASDAQ OMX - NASDAQ BASIC
國家United States of America
郵編10001
電話18663515907
網址https://lifemd.com/
公司代碼LFMD
上市日期Jul 11, 2001
CEOSchreiber (Justin)

LifeMD Inc公司高管

名稱
名稱/職務
職務
持股
持股變動
Mr. Justin Schreiber
Mr. Justin Schreiber
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
2.85M
+7.23%
Mr. Stefan Galluppi
Mr. Stefan Galluppi
Chief Innovation Officer
Chief Innovation Officer
1.79M
+1.71%
Mr. Nicholas P. Alvarez
Mr. Nicholas P. Alvarez
Chief Acquisition Officer
Chief Acquisition Officer
495.71K
-13.14%
Mr. William J. (Will) Febbo
Mr. William J. (Will) Febbo
Director
Director
480.00K
+88.24%
Ms. Jessica Friedeman
Ms. Jessica Friedeman
Chief Marketing Officer
Chief Marketing Officer
220.00K
+29.41%
Mr. Roberto (Bob) Simon
Mr. Roberto (Bob) Simon
Independent Director
Independent Director
153.18K
+17.10%
Mr. Dennis Wijnker
Mr. Dennis Wijnker
Chief Technology Officer
Chief Technology Officer
135.00K
+22.73%
Dr. Joan Larovere
Dr. Joan Larovere
Independent Director
Independent Director
107.05K
+26.41%
Mr. Shane Biffar
Mr. Shane Biffar
Chief Compliance Officer and Deputy General Counsel
Chief Compliance Officer and Deputy General Counsel
40.00K
-73.33%
Mr. Calum Macrae, M.D., Ph.D.
Mr. Calum Macrae, M.D., Ph.D.
Independent Director
Independent Director
--
--
查看更多
名稱
名稱/職務
職務
持股
持股變動
Mr. Justin Schreiber
Mr. Justin Schreiber
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
2.85M
+7.23%
Mr. Stefan Galluppi
Mr. Stefan Galluppi
Chief Innovation Officer
Chief Innovation Officer
1.79M
+1.71%
Mr. Nicholas P. Alvarez
Mr. Nicholas P. Alvarez
Chief Acquisition Officer
Chief Acquisition Officer
495.71K
-13.14%
Mr. William J. (Will) Febbo
Mr. William J. (Will) Febbo
Director
Director
480.00K
+88.24%
Ms. Jessica Friedeman
Ms. Jessica Friedeman
Chief Marketing Officer
Chief Marketing Officer
220.00K
+29.41%
Mr. Roberto (Bob) Simon
Mr. Roberto (Bob) Simon
Independent Director
Independent Director
153.18K
+17.10%

收入明細

由於公司未披露,未能獲取相關數據
由於公司未披露,未能獲取相關數據
業務
地區
由於公司未披露,未能獲取相關數據

股東統計

更新時間: 11月17日 週一
更新時間: 11月17日 週一
持股股東
股東類型
持股股東
持股股東
佔比
Schreiber (Justin)
5.93%
BlackRock Institutional Trust Company, N.A.
5.21%
The Vanguard Group, Inc.
4.63%
Galluppi (Stefan)
3.71%
Renaissance Technologies LLC
3.39%
其他
77.13%
持股股東
持股股東
佔比
Schreiber (Justin)
5.93%
BlackRock Institutional Trust Company, N.A.
5.21%
The Vanguard Group, Inc.
4.63%
Galluppi (Stefan)
3.71%
Renaissance Technologies LLC
3.39%
其他
77.13%
股東類型
持股股東
佔比
Investment Advisor
20.73%
Individual Investor
17.81%
Investment Advisor/Hedge Fund
10.75%
Hedge Fund
7.90%
Research Firm
2.96%
Venture Capital
0.28%
Pension Fund
0.27%
Bank and Trust
0.09%
Insurance Company
0.03%
其他
39.17%

機構持股

更新時間: 10月5日 週日
更新時間: 10月5日 週日
報告期間
機構數
持股數
持股佔比
持股變動
2025Q3
277
24.14M
53.61%
+2.76M
2025Q2
267
25.16M
55.86%
-4.75M
2025Q1
265
25.52M
57.64%
-4.18M
2024Q4
250
23.83M
55.01%
-4.80M
2024Q3
242
24.90M
57.80%
-2.33M
2024Q2
218
23.83M
56.29%
-290.09K
2024Q1
179
22.61M
56.88%
+2.36M
2023Q4
165
20.18M
54.63%
+3.17M
2023Q3
148
17.40M
50.33%
+1.98M
2023Q2
144
16.05M
50.66%
-1.42M
查看更多

股東持股明細

名稱
持股數
佔比
持股變動
變動比例
公告日期
Schreiber (Justin)
2.85M
6.34%
+192.34K
+7.23%
Apr 23, 2025
BlackRock Institutional Trust Company, N.A.
2.41M
5.35%
+107.80K
+4.68%
Jun 30, 2025
The Vanguard Group, Inc.
2.09M
4.63%
+205.62K
+10.93%
Jun 30, 2025
Galluppi (Stefan)
1.79M
3.96%
+30.00K
+1.71%
Aug 22, 2025
Renaissance Technologies LLC
1.09M
2.41%
+600.10K
+123.45%
Jun 30, 2025
Nuveen LLC
1.14M
2.53%
+854.91K
+300.99%
Jun 30, 2025
State Street Investment Management (US)
1.14M
2.53%
+413.24K
+57.01%
Jun 30, 2025
Geode Capital Management, L.L.C.
925.17K
2.05%
+67.44K
+7.86%
Jun 30, 2025
UBS Financial Services, Inc.
937.33K
2.08%
+859.44K
+1103.45%
Jun 30, 2025
Royce Investment Partners
770.45K
1.71%
-384.78K
-33.31%
Jun 30, 2025
查看更多

持股ETF

更新時間: 12月6日 週六
更新時間: 12月6日 週六
機構名稱
佔比
State Street SPDR S&P Kensho New Econ Comp ETF
0.09%
Vanguard US Multifactor ETF
0.08%
Vanguard US Momentum Factor ETF
0.06%
Principal U.S. Small-Cap ETF
0.06%
iShares Micro-Cap ETF
0.04%
JPMorgan Diversified Return U.S. Small Cap Equity ETF
0.03%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
0.03%
WisdomTree US SmallCap Quality Growth Fund
0.02%
iShares Russell 2000 Growth ETF
0.01%
Global X Russell 2000 ETF
0.01%
查看更多
State Street SPDR S&P Kensho New Econ Comp ETF
佔比0.09%
Vanguard US Multifactor ETF
佔比0.08%
Vanguard US Momentum Factor ETF
佔比0.06%
Principal U.S. Small-Cap ETF
佔比0.06%
iShares Micro-Cap ETF
佔比0.04%
JPMorgan Diversified Return U.S. Small Cap Equity ETF
佔比0.03%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
佔比0.03%
WisdomTree US SmallCap Quality Growth Fund
佔比0.02%
iShares Russell 2000 Growth ETF
佔比0.01%
Global X Russell 2000 ETF
佔比0.01%

分紅派息

近5年累計派現 0.00 美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據

拆合股

公告日期
類型
比率
暫無數據
公告日期
類型
比率
暫無數據

常見問題

LifeMD Inc的前五大股東是誰?

LifeMD Inc的前五大股東如下:
Schreiber (Justin)
持有股份:2.85M
佔總股份比例:6.34%。
BlackRock Institutional Trust Company, N.A.
持有股份:2.41M
佔總股份比例:5.35%。
The Vanguard Group, Inc.
持有股份:2.09M
佔總股份比例:4.63%。
Galluppi (Stefan)
持有股份:1.79M
佔總股份比例:3.96%。
Renaissance Technologies LLC
持有股份:1.09M
佔總股份比例:2.41%。

LifeMD Inc的前三大股東類型是什麼?

LifeMD Inc 的前三大股東類型分別是:
Schreiber (Justin)
BlackRock Institutional Trust Company, N.A.
The Vanguard Group, Inc.

有多少機構持有LifeMD Inc(LFMD)的股份?

截至2025Q3,共有277家機構持有LifeMD Inc的股份,合計持有的股份價值約為24.14M,占公司總股份的53.61% 。與2025Q2相比,機構持股有所增加,增幅為-2.25%。

哪個業務部門對LifeMD Inc的收入貢獻最大?

在--,--業務部門對LifeMD Inc的收入貢獻最大,創收--,占總收入的--% 。
KeyAI